Various methods of cancer screening, such as mammograms and colonoscopies, have been highly beneficial to patients across the world by allowing more effective treatments to be applied earlier. The most recent innovations for diagnosing cancers include genomic blood tests that can detect more cancers at earlier stages than existing screens. If reimbursed and adopted widely, they offer a great potential advance in the war on cancer but unfounded critiques of them misdiagnose their value.
